About Belluscura
Belluscura is a company based in Dallas (United States) founded in 2015. Belluscura has raised $6.38 million across 8 funding rounds from investors including Tekcapital. Belluscura has completed 2 acquisitions, including Nanotether and TMT Acquisition. Belluscura offers products and services including X-PLOR, DISCOV-R, and Accessories. Belluscura operates in a competitive market with competitors including hemovent, Lungpacer, ALung, Breethe and Securisyn, among others.
- Headquarter Dallas, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Belluscura, Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.38 M (USD)
in 8 rounds
-
Latest Funding Round
$4.98 M (USD), Post-IPO
Feb 07, 2025
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Nanotether
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Belluscura
Belluscura offers a comprehensive portfolio of products and services, including X-PLOR, DISCOV-R, and Accessories.
Lightweight device for on-the-go supplemental oxygen therapy.
Compact unit with high oxygen output for active patients.
Items for maintaining and enhancing oxygen concentrator use.
People of Belluscura
Unlock access to complete
Unlock access to complete
Funding Insights of Belluscura
Belluscura has successfully raised a total of $6.38M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $4.98 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Belluscura
Belluscura has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Tekcapital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Technologies from global universities are acquired and commercialized.
|
Locked | Locked | Locked |
Investor details for Belluscura
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Belluscura
Belluscura has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Nanotether and TMT Acquisition.
Investment portfolio details for Belluscura
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of wireless telecommunication infrastructures
|
Locked | Locked | 2021 | Locked | |
|
Technology for accelerating drug candidates via DNA tethers is provided.
|
Locked | Locked | 2012 | Locked |
Complete acquisition details for Belluscura
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Belluscura
Detailed financials for Belluscura
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Belluscura Comparisons
Peer comparison for Belluscura
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Belluscura
Belluscura operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as hemovent, Lungpacer, ALung, Breethe and Securisyn, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Equipment for extracorporeal life support and CO2 removal is developed.
|
|
| Locked | Locked | Locked |
Neurostimulation-based pacer for diaphragm strength is developed.
|
|
| Locked | Locked | Locked |
Extracorporeal CO2 removal systems are developed to supplement mechanical ventilation.
|
|
| Locked | Locked | Locked |
Meditation programs are delivered through a mobile app by Breethe.
|
|
| Locked | Locked | Locked |
Endotracheal tube stabilization systems for ventilated patients are developed.
|
Detailed competitors of Belluscura
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Belluscura
Complete news archive for Belluscura
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Belluscura
Belluscura was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Belluscura is headquartered in Dallas, United States. It is registered at Dallas, Texas, United States.
Belluscura is a funded company, having raised a total of $6.38M across 8 funding rounds to date.
Provider of medical devices for laparoscopic procedures. It offers Passport a single-use, and disposable trocar (laparoscopic access device); Slyde- patient evacuation equipment ; Snap II - Level of Consciousness (LoC) device during general anesthesia, etc. The company aims to provide proprietary medical devices at affordable prices across a wide variety of treatment and diagnostic disciplines.
Belluscura offers X-PLOR, DISCOV-R, and Accessories.
Belluscura has made 2 acquisitions, including Nanotether, and TMT Acquisition.
Belluscura has 1 investor. Key investors include Tekcapital.